Palifermin DDI (Drug Drug Interaction)
NCT00361348 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2014-11-06
Summary
The purpose of this study is to determine if Paliferim interacts with Heparin.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Palifermin
- DRUG
-
Heparin
Sponsors & Collaborators
-
Swedish Orphan Biovitrum
lead INDUSTRY
Principal Investigators
-
MD · Biovitrum AB (publ)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2006-07-31
- Completion
- 2006-07-31
More Related Trials
-
A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B
NCT03075670 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
NCT04158934 ·Status: ACTIVE_NOT_RECRUITING
-
Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B
NCT00956345 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
NCT00056589 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901
NCT00157053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
NCT02506023 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies
NCT03405337 ·Status: COMPLETED
-
Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)
NCT03226678 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Investigating Treatment Factor X in People With Factor X Deficiency
NCT00930176 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors
NCT00221195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.
NCT02246868 ·Status: COMPLETED ·Phase: PHASE3
-
Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype
NCT03946384 ·Status: UNKNOWN
-
Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
NCT01571934 ·Status: COMPLETED
-
Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia
NCT03996486 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A
NCT01205724 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State
NCT01562587 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of IL-11 in DDAVP Unresponsive
NCT00994929 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B
NCT01233440 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients
NCT02231944 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B
NCT03995784 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
NCT05628558 ·Status: UNKNOWN
-
Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
NCT00289536 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating ReFacto AF in Severe Hemophilia A
NCT00037544 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
NCT00777855 ·Status: COMPLETED ·Phase: NA